Viewing Study NCT00948961


Ignite Creation Date: 2025-12-24 @ 12:35 PM
Ignite Modification Date: 2026-02-01 @ 7:21 PM
Study NCT ID: NCT00948961
Status: COMPLETED
Last Update Posted: 2016-06-27
First Post: 2009-07-28
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1
Sponsor: Celldex Therapeutics
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Malignancies View
Keywords:

Keywords

Keyword Brief Keyword Text View
None NYESO1 View
None cancer vaccine View
None immunotherapy View
None breast cancer View
None ovarian cancer View
None non-small cell lung cancer View
None myeloma View
None sarcoma View
None melanoma View
None Resiquimod View
None Poly-ICLC View
None Hiltonol View
None esophageal cancer View
None bladder cancer View
None chondrosarcoma View
None adenocarcinoma View